Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole fails.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Cetuximab can cause eyelash growth, which is rare but manageable.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

The EFH-SLM cream is more effective and gentler for treating excessive hair growth in women.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Menthol-based microemulsions improve skin delivery of finasteride and silodosin.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

A new method improves betulin delivery and shows promise in cancer treatment.

New molecules can prevent cell death in hair follicles.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Topical rapamycin may effectively treat fibrous papules on the face.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Ozenoxacin reduces sebum production, helping manage acne.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.